Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Siamak Moghadam Kia"'
Autor:
Chester V. Oddis, Howard E. Rockette, Lei Zhu, Diane C. Koontz, David Lacomis, Swamy Venturupalli, Siamak Moghadam‐Kia, Dana P. Ascherman, Leslie Crofford, Mazen M. Dimachkie, Floranne Ernste, David Gazeley, Galina Marder, Rohit Aggarwal
Publikováno v:
ACR Open Rheumatology, Vol 4, Iss 11, Pp 983-990 (2022)
Objective To assess the efficacy and tolerability of tocilizumab in a multicenter, randomized, double‐blind, placebo‐controlled trial in refractory adult patients with dermatomyositis (DM) and polymyositis (PM). Methods Thirty‐six subjects with
Externí odkaz:
https://doaj.org/article/3f29f397a65a46d68d5dc727acfb139e
Autor:
Jennifer O Adeghate, Gabrielle R Bonhomme, Chad Indermill, Steven L Taylor, Marcelo Rocha, Siamak Moghadam-Kia, Marie-Hélène Errera
Publikováno v:
Oman Journal of Ophthalmology, Vol 16, Iss 3, Pp 570-572 (2023)
Externí odkaz:
https://doaj.org/article/9bbccc64be8c43d1bae08d0a6f8a33f0
Autor:
Aiyoub Pezeshgi, Muhammed Mubarak, Arjang Djamali, Leila Mostafavi, Siamak Moghadam-Kia, Niloufar Alimohammadi, Payam Peymani, Saharnaz Pezeshgi
Publikováno v:
Journal of Nephropathology, Vol 10, Iss 2, Pp e11-e11 (2021)
Kidney is one of the most predominantly organs affected by coronavirus disease 2019 (COVID-19) after the respiratory and immune systems. Among the renal parenchymal components, the tubulointerstitial compartment is presumed to be the prime target of
Externí odkaz:
https://doaj.org/article/0d7bf49734cd4b709990a416533b26aa
Autor:
Yuji Hosono, Brandon Sie, Iago Pinal-Fernandez, Katherine Pak, Christopher A Mecoli, Maria Casal-Dominguez, Blake M Warner, Mariana J Kaplan, Jemima Albayda, Sonye Danoff, Thomas E Lloyd, Julie J Paik, Eleni Tiniakou, Rohit Aggarwal, Chester V Oddis, Siamak Moghadam-Kia, Carmelo Carmona-Rivera, Jose César Milisenda, Josep Maria Grau-Junyent, Albert Selva-O'Callaghan, Lisa Christopher-Stine, H Benjamin Larman, Andrew Lee Mammen
Publikováno v:
Annals of the Rheumatic Diseases. 82:246-252
ObjectivesIn dermatomyositis (DM), autoantibodies are associated with unique clinical phenotypes. For example, anti-TIF1γ autoantibodies are associated with an increased risk of cancer. The purpose of this study was to discover novel DM autoantibodi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68b314e2df72f3bf2f5f90d994a0b41e
https://doi.org/10.1136/ard-2022-222441
https://doi.org/10.1136/ard-2022-222441
Autor:
Silvia Martinez, Siamak Moghadam-Kia, Rohit Aggarwal, Dana P. Ascherman, Amanda Kocoloski, Chester V. Oddis, David Lacomis
Publikováno v:
JCR: Journal of Clinical Rheumatology. 28:e517-e520
Background/objective Immune-mediated necrotizing myopathy (IMNM) is a subtype of myositis that is associated with a refractory phenotype and poorer prognosis. The aim of the study was to provide single large center experience of outcomes of intraveno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81815fdf64bc4512a4ed91fdbdb0089c
https://doi.org/10.1097/rhu.0000000000001786
https://doi.org/10.1097/rhu.0000000000001786
Autor:
Chester V. Oddis, Rohit Aggarwal, Diane Koontz, Nicole Neiman, Siamak Moghadam-Kia, Didem Saygin, Bonny Rockette-Wagner
Publikováno v:
Rheumatology. 61:2951-2958
Objectives Inflammatory myopathies are characterized by muscle weakness that limits the activities of daily living. Daily step count is an accepted metric of physical activity. Wearable technologies such as Fitbit® enable tracking of daily step coun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff5eb0eeea9a7017543e0884bb414cbd
https://doi.org/10.1093/rheumatology/keab700
https://doi.org/10.1093/rheumatology/keab700
Autor:
Theresa Coles, Siamak Moghadam-Kia, Sedin Dzanko, Kaveh Ardalan, Chester V. Oddis, Diane Koontz, Rohit Aggarwal, Didem Saygin
Publikováno v:
Seminars in Arthritis and Rheumatism. 51:539-546
Objective Idiopathic inflammatory myopathies (IIM) are a group of diseases characterized by muscle weakness, which limit activities of daily living. Patient Reported Outcomes Measurement Information System (PROMIS) is a set of outcome measures develo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afaebaa1fd50e9302a7318df386e66de
https://doi.org/10.1016/j.semarthrit.2021.03.018
https://doi.org/10.1016/j.semarthrit.2021.03.018
Autor:
Arjang Djamali, Aiyoub Pezeshgi, Saharnaz Pezeshgi, Muhammed Mubarak, Payam Peymani, Siamak Moghadam-Kia, Leila Mostafavi, Niloufar Alimohammadi
Publikováno v:
Journal of Nephropathology, 10(2):e11, 1-7. Society of Diabetic Nephropathy Prevention
Kidney is one of the most common organs affected by coronavirus disease 2019 (COVID-19) after the respiratory and immune systems. Among the renal parenchymal components, the tubulointerstitial compartment is presumed to be the prime target of injury
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e259df9911bb03f6459a4265c31a0177
https://doi.org/10.34172/jnp.2021.11
https://doi.org/10.34172/jnp.2021.11
Autor:
Océane Landon-Cardinal, Chester V. Oddis, Didem Saygin, Siamak Moghadam-Kia, Sedin Dzanko, Rohit Aggarwal, Bonny Rockette-Wagner, Yves Allenbach, Nicole Neiman, Diane Koontz
Publikováno v:
Rheumatology. 60:5713-5723
Objective Idiopathic inflammatory myopathies (IIMs) cause proximal muscle weakness, which affects the ability to carry out the activities of daily living. Wearable physical activity monitors (PAMs) objectively assess continuous activity and potential
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a54879e2bf9c30b3cd7bd1b97a3c3c4
https://doi.org/10.1093/rheumatology/keab236
https://doi.org/10.1093/rheumatology/keab236
Autor:
Siamak Moghadam-Kia, Chester V. Oddis
Publikováno v:
Current opinion in pharmacology. 65
As treatment of refractory idiopathic inflammatory myopathies (IIM) has been challenging, there is growing interest in assessing new therapies that target various pathways implicated in the pathogenesis of IIM. In the largest clinical trial to date,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dc91cb7e3956789cc57336cbdb1e1e4
https://pubmed.ncbi.nlm.nih.gov/35724455
https://pubmed.ncbi.nlm.nih.gov/35724455